Search

everythinglearnresearchcommunity

for

Search:↓

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

MC4R gene variants not linked to female hair loss.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

PCOS is a hereditary disorder that can lead to diabetes and heart disease if not treated early.

Keratin 26 affects cashmere goat hair growth and is influenced by various treatments.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

PCOS is a hormonal disorder affecting many women, leading to symptoms like acne and irregular periods, and increasing the risk of diabetes and heart disease.

Exercise and finasteride together improve ovary health in PCOS rats.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Mesenchymal Stem Cells (MSCs) are promising for multiple therapies, but more research is needed to fully understand and optimize their use.

Ganoderma lucidum extract and its component, ganoderic acid A, may effectively prevent hair loss.

Laser treatment improves hair density and increases growth factors in androgenetic alopecia.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

LED light promotes hair growth by stimulating cell proliferation and reducing cell death.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.